CD19 CAR T-Cell Therapy May Be Effective in Treating Resistant Ulcerative Colitis

Studies show that individuals diagnosed with ulcerative colitis have approximately a twofold increased risk of developing colorectal cancer compared with the general population. A study investigating treatment with autologous chimeric…

Continue Reading